Skip to main content

Avestar Capital, LLC

Position in LLY — ELI LILLY & Co

CIK 1704404 New York, NY

Position in LLY

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$10,142,380
+$2,430,109 QoQ
Shares Held
8,456
+0.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.99%
of 13F equity value
Holder Rank
#1,254
of 4,605 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Derivatives in LLY

reported options exposure · as of Mar 31, 2025
CallValue
$1,238,865
CallShares
1,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Avestar Capital, LLC holds $29,224,901 across 12 Drug Manufacturers - General names. LLY ranks #1 (34.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
This page
8,456 $10,142,380

All Filings in LLY

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,142,380 8,456
2026-03-31 $7,712,271 8,385
2025-12-31 $8,172,942 7,605
2025-09-30 $5,110,574 6,698
2025-06-30 $5,847,254 7,501
2025-03-31 $6,261,223 7,581
2025-03-31 $1,238,865 1,500
2024-12-31 $1,775,600 2,300
2024-12-31 $5,264,268 6,819
2024-09-30 $265,782 300
2024-09-30 $5,214,642 5,886
2024-06-30 $452,690 500
2024-06-30 $4,675,382 5,164
2024-03-31 $388,980 500
2024-03-31 $3,369,344 4,331
2023-12-31 $2,058,873 3,532
2023-12-31 $291,460 500
2023-09-30 $268,565 500
2023-09-30 $1,559,825 2,904
2023-06-30 $1,109,606 2,366
2023-03-31 $646,659 1,883
2022-12-31 $700,217 1,914
2022-09-30 $555,838 1,719
2022-06-30 $358,922 1,107
2022-03-31 $250,860 876
2021-12-31 $206,612 748